Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financial Conflict Of Interest FDA Surveillance Must Increase - Henney

This article was originally published in The Tan Sheet

Executive Summary

Increased surveillance of financial conflict of interest is necessary to guard against bias or the perception of bias, FDA Commissioner Jane Henney, MD, indicated at an HHS meeting on human subject protection and financial conflict of interest Aug. 15 at the National Institutes of Health.
Advertisement

Related Content

IoM Research Review Program Certification Standards Slated For April
IoM Research Review Program Certification Standards Slated For April
IoM Research Review Program Certification Standards Slated For April
Conflict Of Interest Document For Trial Participants Advocated By FASEB
Conflict Of Interest Document For Trial Participants Advocated By FASEB
Conflict Of Interest Document For Trial Participants Advocated By FASEB
FDA human clinical studies
OTC "Actual Use Studies" Subject To Financial Disclosure Requirements
OTC "Actual Use Studies" Subject To Financial Disclosure Requirements

Topics

Advertisement
UsernamePublicRestriction

Register

PS091591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel